BG Medicine (NASDAQ:BGMD): Current price $1.72
BG has announced the publication of two studies that demonstrate the clinical utility of repeated galectin-3 testing used as a tool in the assessment of patients with heart failure. The evaluations, which taken together entailed over 3,300 subjects, show that periodic evaluation of galectin-3 levels can aid clinicians in identifying those at greater risk of unplanned hospital admission and cardiovascular morbidity and mortality. BG is a diagnostics firm that concentrates on the development and commercialization of novel cardiovascular tests.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.